Tools & Resources

    WELCOME

    TO THE OPTISIGHT TOOLKIT

    Developed in collaboration with leading retinal experts, Optisight aims to provide practical tools and support to successfully adopt Treat-and-Extend (T&E) dosing in your clinic. It includes resources to enable you to make organisational changes needed to implement T&E dosing as well as ways to effectively communicate changes to your team and patients.

    Translated versions are also available in some countries. For more information, please contact your local Bayer representative.

      RESOURCES FOR YOUR TEAM

      These materials are intended to provide support to your ophthalmology team. They can be used to educate the multidisciplinary team about T&E dosing and provide guidance for successful implementation in practice.

      EDUCATIONAL SLIDE DECK

      To educate and upskill the multidisciplinary team on the benefits of T&E dosing. It includes an explanation of T&E dosing, a comparison with other dosing regimens, and a summary of the evidence from clinical trials and real world practice.

      Educational slide deck
      Download

      Ophthalmologist FAQ on T&E

      Key topics: differences between treatment regimens, benefits of switching to T&E dosing, training requirements, guidance on monitoring of patients, and addressing concerns within your center.

      Ophthalmologist FAQ on T&E
      Download

      Patient discussion guide

      Aid in leading discussions with your patients with neovascular age-related macular degeneration (nAMD), including strategies to address their concerns, to avoid common misconceptions, and ensure they are engaged with their treatment plan.

      Patient discussion guide
      Download

      Clinical case studies

      Best practice case studies of T&E dosing shared by leading experts, including the rationale for choosing T&E dosing, details of the treatment plan, and patient outcomes.

      Clinical case studies
      Download

      RESOURCES FOR YOUR CENTER

      These materials are intended to help you make any changes needed to the organisation of your clinical care service for the successful implementation of T&E dosing.

      Service redesign case studies

      Examples from experts on clinic optimization to implement T&E dosing, including barriers faced by the center and how they were overcome.

      Service Redesign Case Studies
      Download

      RESOURCES FOR YOUR PATIENTS

      These materials are intended to provide support for your patients receiving T&E dosing and their caregivers. The resources below can be used as tools during appointments and shared as printed copies for patients to take home.

      Patient resource pack

      A detailed explanation of T&E dosing, its benefits, and what patients should expect at appointments, designed to help reassure patients who are anxious or concerned in order to improve their understanding.

      Patient resource pack
      Download

      Patient tracking card

      A simple card for patient monitoring of appointments and visual gains, intended to overcome low adherence. This may help patients take ownership of their treatment plan and track changes in their disease.

      Patient tracking card
      Download

      PODCASTS

      EXPERT RECOMMENDATIONS
      FROM THE VISION ACADEMY

      OPTIMAL ANTI-VEGF THERAPY REGIMEN-VISION ACADEMY RECOMMENDATIONS

      Podcast

      Symposia

      VIDEOS

      Video title

      YYMMDD Author/Uploaded by
      Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

      UNSURPASSED VISION GAINS AND OPTIMIZED PATIENT OUTCOMES IN DME

      Video title

      YYMMDD Author/Uploaded by
      Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

      KEEPING A STEP AHEAD OF THE DISEASE: PROACTIVE TREATMENT FOR nAMD

      Video title

      YYMMDD Author/Uploaded by
      Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

      EMERGING EVIDENCE: MOLECULAR PROPERTIES AND PATIENT OUTCOMES

      MEET THE EXPERTS @ EURETINA

      Video title

      YYMMDD Author/Uploaded by
      Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

      T&E IN THE CLINIC: HOW DO VISION AND FLUID WORK TOGETHER TO DRIVE INDIVIDUALIZED ANTI-VEGF THERAPY?

      Video title

      YYMMDD Author/Uploaded by
      Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

      WHY DOES MOLECULAR DESIGN MATTER WHEN TREATING DME?

      Video title

      YYMMDD Author/Uploaded by
      Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

      UNDERSTANDING MOLECULAR DESIGN AND DYNAMICS TO INFORM PROACTIVE TREATMENT EXTENSION

      This website contains information on EYLEA® (aflibercept solution for injection) which is based on the Summary of Product Characteristics (SPC) as approved by the European Commission. It is intended to provide information to an international audience outside the USA and UK. In countries outside the EU the local Product Information applies.

      PP-EYL-ALL-0513-1. Last updated on 29/02/2020